Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy: Preliminary results of the German-Austrian multicenter trial

Strahlentherapie und Onkologie

Volumn 180, Issue 10, 2004, Pages 642-649

  Ott, Oliver J ^a   Pötter, Richard ^b   Hammer, Josef ^c   Hildebrandt, Guido ^d   Lotter, Michael ^a   Resch, Alexandra ^b   Pöhls, Uwe ^a   Beckmann, Matthias W ^a   Sauer, Rolf ^a   Strnad, Vratislav ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c Hospital Barmherzige Schwestern Linz   (Austria)

^d UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Accelerated partial breast irradiation; Brachytherapy; PDR

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GOSERELIN; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ACCELERATED PARTIAL BREAST IRRADIATION; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BRACHYTHERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL TRIAL; FEMALE; FIBROSIS; FOLLOW UP; HUMAN; IMPLANT; IRRADIATION; MAJOR CLINICAL STUDY; MASTECTOMY; MULTICENTER STUDY; PAIN; RADIATION DERMATITIS; RADIATION DOSE; RADIATION INJURY; TELANGIECTASIA; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; CATHETERIZATION; CAUSALITY; COMORBIDITY; FEMALE; GERMANY; HUMANS; INCIDENCE; IRIDIUM RADIOISOTOPES; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREVALENCE; PROGNOSIS; RADIATION INJURIES; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 5444263710     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-1294-2     Document Type: Article

References (71)

1. Arthur DW, Koo D, Zwicker RD, et al. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys 2003;56:681-9.
2. Arthur DW, Vicini FA, Kuske RR, et al. Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy 2002;1:184-90.
3. Astrahan MA, Jozsef G, Streeter OE Jr. Optimization of MammoSite therapy. Int J Radiat Oncol Biol Phys 2004;58:220-32.
4. Baglan KL, Martinez AA, Frazier RC, et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2001;50:1003-11.
5. Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 2003;55:302-11.
6. Bartelink H, Horiot JC, Poortmans P, et al. European Organization for Research and Treatment of Cancer. Radiotherapy and Breast Cancer Groups. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001;345:1378-87.
7. Bayerl A, Frank D, Lenz A, et al. Local tumor control and cosmetic outcome following breast-conserving surgery and radiation up to a total dose of 56 Gy without boost in breast cancer. Strahlenther Onkol 2001;177:25-32.
8. Berle L, Lowther D, DiPetrillo T, et al. A phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 2001;51: Suppl 1:5.
9. Ciocca M, Orecchia R, Garibaldi C, et al. In vivo dosimetry using radiochromic films during intraoperative electron beam radiation therapy in early-stage breast cancer. Radiother Oncol 2003;69:285-9.
10. Clark RM, McCulloch PB, Levine MN, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 1992;84:683-9.
11. Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 1996;88:1659-64.
12. Clarke DH, Vicini F, Jacobs H, et al. High dose rate brachytherapy for breast cancer. In: Nag S, ed. High dose rate brachytherapy: a textbook. Armonk-New York: Futura, 1994:321-9.
13. Ebert MA, Carruthers B. Dosimetric characteristics of a low-kV intra-operative x-ray source: implications for use in a clinical trial for treatment of low-risk breast cancer. Med Phys 2003;30:2424-31.
14. Edmundson GK, Vicini FA, Chen PY, et al. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 2002;52:1132-9.
15. Fentiman IS, Poole C, Tong D, et al. Inadequacy of iridium implant as a sole radiation treatment for operable breast cancer. Eur J Cancer 1996;32A: 608-11.
16. Fisher B, Anderson S. Conservative surgery for the management of invasive and non-invasive carcinoma of the breast: NSABP trials. World J Surg 1994;18:63-9.
17. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-61.
18. Formenti SC, Rosenstein B, Skinner KA, et al. T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients - pilot feasibility study. Radiology 2002;222:171-8.
19. Gatzemeier W, Orecchia R, Gatti G, et al. Intraoperative radiotherapy (IORT) in treatment of breast carcinoma - a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Milano. Strahlenther Onkol 2001;177:330-7.
20. Hammer J, Mazeron JJ, Van Limbergen E. Breast boost - why, how, when? Strahlenther Onkol 1999;175:478-83.
21. Harms W, Krempien R, Hensley FW, et al. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer. Strahlenther Onkol 2002;178:607-14.
22. Holli K, Saaristo R, Isola J, et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer 2001;84:164-9.
23. Intra M, Gatti G, Luini A, et al. Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer. Arch Surg 2002;137:737-40.
24. Johansson B, Karlsson L, Liljegren G, et al. PDR brachytherapy as the sole adjuvant radiotherapy after breast conserving surgery of T1-2 breast cancer. In: Program & Abstracts, 10th International Brachytherapy Conference. Madrid: Nucletron, 2000;127.abstract.
25. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003;55:289-93.
26. Keisch M, Vicini F, Kuske R, et al. Two-year outcome with the mammosite breast brachytherapy applicator: factors associated with optimal cosmetic results when performing partial breast irradiation. Int J Radiat Oncol Biol Phys 2003;57:Suppl:S315.
27. King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 2000;180:299-304.
28. Krishnan L, Jewell WR, Tawfik OW, et al. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J 2001;7:91-6.
29. Kuerer HM, Pawlik TM, Strom EA. Intracavitary balloon brachytherapy for breast cancer: surgical considerations. In regard to Keisch M, Vicini F, Kuske RR, et al., Int J Radiat Oncol Biol Phys 2003;55:289-93. Int J Radiat Oncol Biol Phys 2003;57:900-2.
30. Kuerer HM, Pawlik TM, Strom EA. Intracavitary balloon brachytherapy for breast cancer: surgical considerations. In regard to Keisch M, Vicini F, Kuske RR, et al., Int J Radiat Oncol Biol Phys 2003;55:289-93. Int J Radiat Oncol Biol Phys 2003;57:900-2.
31. Kuske RR, Bolton JS, Fuhrman G, et al. Wide volume brachytherapy alone for select breast cancers: the ten year experience of the Ochsner Clinic. In: Program & Abstracts, 10th International Brachytherapy Conference. Madrid: Nucletron, 2000;117.abstract.
32. Kuske RR, Bolton JS, McKinnon WMP, et al. 6.5-year results of a prospective phase I-II trial of wide-volume brachytherapy as the sole method of breast irradiation in Tis, T1, T2, NO-1 breast cancer. Radiother Oncol 2000;55: Suppl 1:26.abstract.
33. Kuske RR, Winter K, Arthur D, et al. A phase I/II trial of brachytherapy alone following lumpectomy for select breast cancer: toxicity analysis of Radiation Therapy Oncology Group 95-17. Int J Radiat Oncol Biol Phys 2002;54:Suppl:87.
34. Lawenda BD, Taghian AG, Kachnic LA, et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 2003;56:671-80.
35. Liljegren G, Holmberg L, Adami HO, et al, for the Uppsala-Oreboro Breast Cancer Study Group. Sector resection with or without post-operative radiotherapy for stage I breast cancer: five-year results of a randomized trial. J Natl Cancer Inst 1994;86:717-22.
36. Liljegren G, Holmberg L, Bergh J, et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 1999;17:2326-33.
37. Magee B, Swindell R, Harris M, et al. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial. Radiother Oncol 1996;39:223-7.
38. Martinez A, Chen P, Benitez P, et al. Accelerated partial breast irradiation via interstitial brachytherapy as the sole radiation modality for treatment of early stage breast cancer. Radiother Oncol 2003;66:Suppl 1:S15.
39. Mayer A, Naszály A, Patyánik M, et al. Perioperative brachytherapy for pretreated chest wall recurrence of breast cancer. Strahlenther Onkol 2002; 178:633-6.
40. 192Ir radical implant in early breast cancer: a quality assurance and dosimetry study. Int J Radiat Oncol Biol Phys 2003;56:690-6.
41. Orecchia R, Ciocca M, Lazzari R, et al. Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. Breast 2003;12:483-90.
42. Ott OJ, Strnad V. [Only interstitial brachytherapy of the tumor bed as an alternative to teletherapy in selected breast cancer patients.] Strahlenther Onkol 2001;177:558-9.
43. Perera F, Chisela F, Engel J, et al. Method of localization and implantation of the lumpectomy cavity for high dose rate brachytherapy after conservative surgery for T1 and T2 breast cancer. Int J Radiat Oncol Biol Phys 1995;31:959-65.
44. Perera F, Engel F, Holliday R, et al. Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study. J Surg Oncol 1997;65:263-8.
45. Perera F, Yu E, Engel J, et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up. Int J Radiat Oncol Biol Phys 2003;57:1239-46.
46. Petit JY, Veronesi U, Orecchia R, et al. The nipple-sparing mastectomy: early results of a feasibility study of a new application of perioperative radiotherapy (ELIOT) in the treatment of breast cancer when mastectomy is indicated. Tumori 2003;89:288-91.
47. Polgar C, Fodor J, Major T, et al. Radiotherapy confined to the tumor bed following breast conserving surgery current status, controversies, and future projects. Strahlenther Onkol 2002;178:597-606.
48. Polgar C, Fodor J, Nemeth G, et al. HDR brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast conserving surgery: six-year results of a comparative study using matched controls. Radiother Oncol 2003;66:Suppl 1:S14.
49. Polgar C, Fodor J, Orosz Z, et al. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer: first results of the randomized Budapest boost trial. Strahlenther Onkol 2002;178:615-23.
50. Polgar C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 2002;80:121-8.
51. Ribeiro GG, Dunn G, Swindell R, et al. Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial. Clin Oncol (R Coll Radiol) 1990;2:27-34.
52. Ribeiro GG, Dunn G, Swindell R, et al. Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial. Clin Oncol (R Coll Radiol) 1993;5:278-83.
53. Samuel LM, Dewar JA, Preece PE, et al. A pilot study of radical radiotherapy using a perioperative implant following wide local excision for carcinoma of the breast. Breast 1999;8:95-7.
54. Sauer R, Schauer A, Rauschecker HF, et al. Breast preservation versus mastectomy in early breast cancer - 1991 update of the GBSG 1 - protocol and prognostic factors. Strahlenther Onkol 1992;168:191-202.
55. Schuck A, Konemann S, Heinen K, et al. Microscopic residual disease is a risk factor in the primary treatment of breast cancer. Strahlenther Onkol 2002;178:307-13.
56. Shah HK, Patel RR, Kolton M, et al. Toxicity and cosmetic outcomes of high dose rate interstitial accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2003;57:Suppl:S314.
57. Streeter OE Jr, Vicini FA, Keisch M, et al. MammoSite radiation therapy system. Breast 2003;12:491-6.
58. Strnad V, Ott OJ, Pötter R, et al. A German-Austrian multicenter phase II trial: interstitial brachytherapy alone after breast conserving surgery - toxicity analysis. Radiother Oncol 2003;66:Suppl 1:S14.
59. Vaidya OS, Baum M, Tobias JS, et al. Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol 2001;12:1075-80.
60. Vaidya JS, Baum M, Tobias JS, et al. The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. Eur J Surg Oncol 2002;28:447-54.
61. Veronesi U, Gatti G, Luini A, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg 2003;138:1253-6.
62. Veronesi U, Gatti G, Luini A, et al. Intraoperative radiation therapy for breast cancer: technical notes. Breast J 2003;9:106-12.
63. Veronesi U, Orecchia R, Luini A, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 2001;37:2178-83.
64. Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast: long-term results of three randomised trials of 1973 patients. Eur J Cancer 1995;31A:1574-81.
65. Vicini F, Kini VR, Chen P, et al. Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy. J Surg Oncol 1999;70:33-40.
66. Vicini FA, Chen PY, Fraile M, et al. Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: preliminary results of a pilot trial. Int J Radiat Oncol Biol Phys 1997;38:301-10.
67. Vicini FA, Kestin L, Chen P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003;95:1205-10.
68. Vicini FA, Remouchamps V, Wallace M, et al. Ongoing clinical experience utilizing 3-D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003;57:1247-53.
69. Wazer DE, Berle L, Graham R, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 2002;53:889-97.
70. Wazer DE, Lowther D, Boyle T, et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2001;50:107-11.
71. Zannis VJ, Walker LC, Barclay-White B, et al. Postoperative ultrasound-guided percutaneous placement of a new breast brachytherapy balloon catheter. Am J Surg 2003;186:383-5.